US company Moderna seeks US approval for Covid-19 vaccine

American drug manufacturer Moderna has requested the US government, the Food and Drug Administration (FDA) and the European Medicine Agency to give full approval to emergency use for its corona vaccine. Moderna once again claimed on Monday that their covid vaccine was 94.1 percent effective on corona patients.
Maderna claims that this vaccine has been effective in people of all classes and groups. Moderna, a frontrunner in the development of the Corona vaccine, has claimed that the vaccine is 94.1% effective after the Phase III trial. More than 30,000 people have participated in the trial of Moderna’s vaccine. The company claimed that its vaccine was 100% effective in preventing patients from reaching critical condition.

Moderna is the second American vaccine after Pfizer, which is set to hit the market soon with Corona vaccine. Pfizer sought permission from the US Food and Drug Administration (FDA) about a week ago to allow emergency use. By the end of this year, Moderna is set to provide 20 million doses. At the end of next year, the company will make 50 billion to one billion doses available in the market.

The Chief Medical Officer of the company, Dr. Tal Zaks, said that we saved many lives during the vaccine test itself. He said that when we came to know about it in the final results, then tears came out with joy. Moderna is expected to submit its data to the FDA on December 17, while Pfizer is to submit its data and results on December 10. Both these vaccines are of two doses. Cold chains are needed for both. Both companies had claimed that their vaccine was effective at up to 95 percent in protecting corona from mild and severe infections. These companies had said that the emergency use of the vaccine should be approved given its good record.